{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T15:25:54Z","timestamp":1785252354137,"version":"3.55.0"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.intimp.2025.114036","type":"journal-article","created":{"date-parts":[[2025,1,7]],"date-time":"2025-01-07T20:30:31Z","timestamp":1736281831000},"page":"114036","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Knockdown of GSDMD inhibits pyroptosis in psoriasis by blocking the NOD-like receptor signaling pathway"],"prefix":"10.1016","volume":"147","author":[{"given":"Shuqin","family":"Lai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huaqing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojuan","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjie","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiwei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunli","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaolin","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3441-037X","authenticated-orcid":false,"given":"Longnian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10281","key":"10.1016\/j.intimp.2025.114036_b0005","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/S0140-6736(20)32549-6","article-title":"Psoriasis","volume":"397","author":"Griffiths","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.intimp.2025.114036_b0010","article-title":"National, regional, and worldwide epidemiology of psoriasis: systematic analysis and modelling study","volume":"369","author":"Parisi","year":"2020","journal-title":"BMJ"},{"issue":"Suppl 2","key":"10.1016\/j.intimp.2025.114036_b0015","article-title":"Psoriasis: epidemiology, clinical features, and quality of life","volume":"64","author":"Langley","year":"2005","journal-title":"Ann Rheum Dis"},{"issue":"17","key":"10.1016\/j.intimp.2025.114036_b0020","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241713313","article-title":"Challenges and Future Trends in the Treatment of Psoriasis","volume":"24","author":"Lee","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"9","key":"10.1016\/j.intimp.2025.114036_b0025","doi-asserted-by":"crossref","first-page":"4310","DOI":"10.7150\/thno.71086","article-title":"Pyroptosis in inflammatory diseases and cancer","volume":"12","author":"Rao","year":"2022","journal-title":"Theranostics"},{"issue":"7","key":"10.1016\/j.intimp.2025.114036_b0030","doi-asserted-by":"crossref","DOI":"10.1111\/exd.15135","article-title":"Pyroptosis and its role in autoimmune skin disease","volume":"33","author":"Yao","year":"2024","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.intimp.2025.114036_b0035","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.751533","article-title":"The Versatile Gasdermin Family: Their Function and Roles in Diseases","volume":"12","author":"Zou","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.intimp.2025.114036_b0040","first-page":"7575","volume":"526","author":"Jianjin","year":"2015","journal-title":"Cleavage of GSDMD by Inflammatory Caspases Determines Pyroptotic Cell Death."},{"issue":"17","key":"10.1016\/j.intimp.2025.114036_b0045","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241713047","article-title":"Is Upregulated in Psoriatic Skin-A New Potential Link in the Pathogenesis of Psoriasis","volume":"24","author":"Nowowiejska","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"9","key":"10.1016\/j.intimp.2025.114036_b0050","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/s41419-023-06094-3","article-title":"Gasdermin D-mediated keratinocyte pyroptosis as a key step in psoriasis pathogenesis","volume":"14","author":"Lian","year":"2023","journal-title":"Cell Death Dis"},{"issue":"8","key":"10.1016\/j.intimp.2025.114036_b0055","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/s41577-019-0165-0","article-title":"The NLRP3 inflammasome: molecular activation and regulation to therapeutics","volume":"19","author":"Swanson","year":"2019","journal-title":"Nat Rev Immunol"},{"issue":"24","key":"10.1016\/j.intimp.2025.114036_b0060","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222413397","article-title":"Toll-Like Receptors (TLRs), NOD-Like Receptors (NLRs), and RIG-I-Like Receptors (RLRs) in Innate Immunity. TLRs, NLRs, and RLRs Ligands as Immunotherapeutic Agents for Hematopoietic Diseases","volume":"22","author":"Wicherska-Pawlowska","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"11","key":"10.1016\/j.intimp.2025.114036_b0065","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1038\/s41401-020-00603-2","article-title":"NOD-like receptors in autoimmune diseases","volume":"42","author":"Chen","year":"2021","journal-title":"Acta Pharmacol Sin"},{"key":"10.1016\/j.intimp.2025.114036_b0070","doi-asserted-by":"crossref","first-page":"22745","DOI":"10.1038\/srep22745","article-title":"NOD-like receptor signaling and inflammasome-related pathways are highlighted in psoriatic epidermis","volume":"6","author":"Tervaniemi","year":"2016","journal-title":"Sci Rep"},{"issue":"7","key":"10.1016\/j.intimp.2025.114036_b0075","doi-asserted-by":"crossref","first-page":"e1303","DOI":"10.1002\/iid3.1303","article-title":"Wogonin ameliorates the proliferation, inflammatory response, and pyroptosis in keratinocytes via NOD-like receptor family pyrin domain containing 3\/Caspase-1\/Gasdermin-D pathway","volume":"12","author":"Ma","year":"2024","journal-title":"Immun Inflamm Dis"},{"issue":"1","key":"10.1016\/j.intimp.2025.114036_b0080","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s40659-020-00316-0","article-title":"Daphnetin inhibits proliferation and inflammatory response in human HaCaT keratinocytes and ameliorates imiquimod-induced psoriasis-like skin lesion in mice","volume":"53","author":"Gao","year":"2020","journal-title":"Biol Res"},{"issue":"11","key":"10.1016\/j.intimp.2025.114036_b0085","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1038\/s41419-023-06234-9","article-title":"Sulforaphane alleviates psoriasis by enhancing antioxidant defense through KEAP1-NRF2 Pathway activation and attenuating inflammatory signaling","volume":"14","author":"Ma","year":"2023","journal-title":"Cell Death Dis"},{"issue":"8","key":"10.1016\/j.intimp.2025.114036_b0090","doi-asserted-by":"crossref","DOI":"10.3390\/cells8080807","article-title":"Keratin 6, 16 and 17-Critical Barrier Alarmin Molecules in Skin Wounds and Psoriasis","volume":"8","author":"Zhang","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.intimp.2025.114036_b0095","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.abb.2019.02.008","article-title":"NOD-like receptors and inflammasomes: A review of their canonical and non-canonical signaling pathways","volume":"670","author":"Platnich","year":"2019","journal-title":"Arch Biochem Biophys"},{"key":"10.1016\/j.intimp.2025.114036_b0100","article-title":"The Regulation and Modification of GSDMD Signaling in Diseases","volume":"13","author":"Li","year":"2022","journal-title":"Front Immunol"},{"issue":"4","key":"10.1016\/j.intimp.2025.114036_b0105","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1111\/bjd.18245","article-title":"Management of psoriasis as a systemic disease: what is the evidence?","volume":"182","author":"Korman","year":"2020","journal-title":"Br J Dermatol"},{"issue":"12","key":"10.1016\/j.intimp.2025.114036_b0110","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1038\/cr.2015.139","article-title":"Gasdermin D is an executor of pyroptosis and required for interleukin-1beta secretion","volume":"25","author":"He","year":"2015","journal-title":"Cell Res"},{"key":"10.1016\/j.intimp.2025.114036_b0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.112041","article-title":"Periplogenin inhibits pyroptosis of fibroblastic synoviocytes in rheumatoid arthritis through the NLRP3\/Caspase-1\/GSDMD signaling pathway","volume":"133","author":"Ma","year":"2024","journal-title":"Int Immunopharmacol"},{"issue":"9","key":"10.1016\/j.intimp.2025.114036_b0120","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.1016\/j.apsb.2021.02.006","article-title":"Gasdermin D in pyroptosis","volume":"11","author":"Burdette","year":"2021","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.intimp.2025.114036_b0125","doi-asserted-by":"crossref","DOI":"10.1002\/bab.2668","article-title":"Salidroside alleviates imiquimod-induced psoriasis by inhibiting GSDMD-driven keratinocyte pyroptosis","author":"Wang","year":"2024","journal-title":"Biotechnol Appl Biochem"},{"issue":"4","key":"10.1016\/j.intimp.2025.114036_b0130","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1080\/14740338.2020.1736553","article-title":"A safety evaluation of dimethyl fumarate in moderate-to-severe psoriasis","volume":"19","author":"Reszke","year":"2020","journal-title":"Expert Opin Drug Saf"},{"issue":"1","key":"10.1016\/j.intimp.2025.114036_b0135","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s40265-017-0854-6","article-title":"Dimethyl Fumarate: A Review in Moderate to Severe Plaque Psoriasis","volume":"78","author":"Blair","year":"2018","journal-title":"Drugs"},{"issue":"6511","key":"10.1016\/j.intimp.2025.114036_b0140","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1126\/science.abb9818","article-title":"Succination inactivates gasdermin D and blocks pyroptosis","volume":"369","author":"Humphries","year":"2020","journal-title":"Science"},{"issue":"7","key":"10.1016\/j.intimp.2025.114036_b0145","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1038\/s41590-020-0669-6","article-title":"FDA-approved disulfiram inhibits pyroptosis by blocking gasdermin D pore formation","volume":"21","author":"Hu","year":"2020","journal-title":"Nat Immunol"},{"key":"10.1016\/j.intimp.2025.114036_b0150","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.csbj.2023.11.049","article-title":"PANoptosis signaling enables broad immune response in psoriasis: From pathogenesis to new therapeutic strategies","volume":"23","author":"Hu","year":"2024","journal-title":"Comput Struct Biotechnol J"},{"issue":"11","key":"10.1016\/j.intimp.2025.114036_b0155","doi-asserted-by":"crossref","first-page":"2288","DOI":"10.1016\/j.cell.2023.04.025","article-title":"A 360 degrees view of the inflammasome: Mechanisms of activation, cell death, and diseases","volume":"186","author":"Barnett","year":"2023","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.intimp.2025.114036_b0160","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.cell.2020.02.002","article-title":"Structural Mechanism for GSDMD Targeting by Autoprocessed Caspases in Pyroptosis","volume":"180","author":"Wang","year":"2020","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.intimp.2025.114036_b0165","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1002\/cpdd.1162","article-title":"Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the Oral NLRP3 Inflammasome Inhibitor ZYIL1: First-in-Human Phase 1 Studies (Single Ascending Dose and Multiple Ascending Dose)","volume":"12","author":"Parmar","year":"2023","journal-title":"Clin Pharmacol Drug Dev"},{"key":"10.1016\/j.intimp.2025.114036_b0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2022.110122","article-title":"Chlorquinaldol inhibits the activation of nucleotide-binding oligomerization domain-like receptor family pyrin domain-containing protein 3 inflammasome and ameliorates imiquimod-induced psoriasis-like dermatitis in mice","volume":"365","author":"Chen","year":"2022","journal-title":"Chem Biol Interact"},{"issue":"17","key":"10.1016\/j.intimp.2025.114036_b0175","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241713528","article-title":"Inhibition of NLRP3 Inflammasome Activation by 3H-1,2-Dithiole-3-Thione: A Potential Therapeutic Approach for Psoriasis Treatment","volume":"24","author":"Shih","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.intimp.2025.114036_b0180","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/imr.12902","article-title":"NOD1 and NOD2 in inflammatory and infectious diseases","volume":"297","author":"Trindade","year":"2020","journal-title":"Immunol Rev"},{"issue":"9","key":"10.1016\/j.intimp.2025.114036_b0185","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20202637","article-title":"ASC deglutathionylation is a checkpoint for NLRP3 inflammasome activation","volume":"218","author":"Li","year":"2021","journal-title":"J Exp Med"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576925000256?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576925000256?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T04:28:16Z","timestamp":1740112096000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576925000256"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":37,"alternative-id":["S1567576925000256"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2025.114036","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Knockdown of GSDMD inhibits pyroptosis in psoriasis by blocking the NOD-like receptor signaling pathway","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2025.114036","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"114036"}}